+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pompe Disease Market by Product (Alglucosidase Alfa, Avalglucosidase Alfa), Patient Type (Infantile Onset, Late Onset), Treatment Regimen, Distribution Channel - Global Forecast 2025-2030- Product Image
Pompe Disease Market by Product (Alglucosidase Alfa, Avalglucosidase Alfa), Patient Type (Infantile Onset, Late Onset), Treatment Regimen, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Pompe Disease Market by Product (Alglucosidase Alfa, Avalglucosidase Alfa), Patient Type (Infantile Onset, Late Onset), Treatment Regimen, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968988
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Pompe Disease Market is evolving against a backdrop of rapid therapeutic innovation and refined healthcare delivery models. This market intelligence resource empowers senior executives to anticipate changes in treatment standards and patient access, enabling confident, opportunity-driven decisions amid complex, dynamic conditions.

Market Snapshot: Pompe Disease Market Overview

The Pompe Disease Market grew from USD 1.59 billion in 2024 to USD 1.68 billion in 2025. It is expected to continue growing at a CAGR of 5.63%, reaching USD 2.21 billion by 2030.

Scope & Segmentation

This comprehensive report delivers an in-depth view of the Pompe Disease Market across multiple strategic dimensions, offering clear insight into current and emerging dynamics influencing therapy adoption and value chain shifts.

  • Product: Alglucosidase Alfa, Avalglucosidase Alfa
  • Patient Type: Infantile Onset, Late Onset
  • Treatment Regimen: Biweekly Infusion, Monthly Infusion
  • Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Specialty Pharmacy
  • Geographies: Americas (including United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Sanofi S.A., Amicus Therapeutics, Inc., Shionogi Inc., Maze Therapeutics, GeneCradle Pharmaceutical

Pompe Disease Market: Key Takeaways

  • Therapeutic strategies are shifting with advancements in enzyme replacement therapies and targeted gene editing platforms, broadening potential treatment options and improving patient stratification capabilities.
  • Early diagnosis is becoming more prevalent due to newborn screening integration and development of precise biomarker technologies, positioning stakeholders for earlier intervention.
  • Remote monitoring and telemedicine are reshaping patient management, reducing barriers related to specialist access and enabling more consistent, patient-centered care trajectories.
  • Enhanced focus on supply chain resilience is leading to active renegotiation of supplier agreements and adoption of alternative sourcing to sustain product availability during periods of regulatory disruption.
  • Collaborations between biopharmaceutical companies, diagnostic developers, and healthcare distributors are fostering data-driven product development and expanding access through improved distribution models.
  • Market segmentation by product, patient profile, and treatment regimen supports tailored resource allocation, enabling improved adherence, patient support programs, and streamlined healthcare delivery.

United States Tariff Impact: Supply Chain and Operational Considerations

Recently implemented U.S. tariff policies introduced higher import costs for biologics and critical components within the Pompe Disease therapeutics supply chain. As a result, manufacturers are reassessing longstanding contracts and diversifying supplier relationships to ensure continuity of care. Risk-sharing frameworks and predictive supply analytics now play a greater role in cost containment and reimbursement balance, fostering a more adaptive, collaborative industry ecosystem during volatility.

Methodology & Data Sources

This market assessment integrates quantitative analytics and qualitative analysis to provide a multidimensional perspective. Secondary research encompasses peer-reviewed journals, regulatory reports, and regional guidelines, while insights from primary interviews with clinical, supply chain, and key opinion leaders add expertise-driven context. Rigorous data triangulation and peer review processes validate findings and recommendations.

Why This Report Matters: Outcomes for Senior Decision-Makers

  • Informs go-to-market strategy formulation, allowing for nuanced navigation of shifting patient needs and payer landscapes.
  • Enables precise product positioning and resource planning through robust segmentation and region-specific dynamics.
  • Supports competitive intelligence and partnership exploration by analyzing market trends, regulatory shifts, and stakeholder actions.

Conclusion

The Pompe Disease Market is defined by innovation, operational agility, and strategic collaboration. Stakeholders leveraging this analysis will be better equipped to adapt, drive clinical outcomes, and secure leadership amid a transforming global landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of next generation gene replacement therapies targeting acid alpha glucosidase expression in skeletal muscle and cardiac tissue
5.2. Growing adoption of home-based enzyme replacement infusion services supported by telehealth monitoring and digital adherence tools
5.3. Accelerating newborn screening programs to facilitate early Pompe disease diagnosis and treatment initiation in high risk populations
5.4. Emergence of chaperone assisted enzyme stabilization approaches to improve intracellular delivery of therapeutic proteins in Pompe patients
5.5. Shift toward value based reimbursement models driven by real world evidence of long term outcomes and healthcare resource utilization
5.6. Development of investigational CRISPR based gene editing candidates aimed at durable correction of GAA gene mutations for infantile form Pompe disease
5.7. Increasing partnerships between biopharma and patient advocacy groups to co design clinical trials and patient centric care pathways
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pompe Disease Market, by Product
8.1. Introduction
8.2. Alglucosidase Alfa
8.3. Avalglucosidase Alfa
9. Pompe Disease Market, by Patient Type
9.1. Introduction
9.2. Infantile Onset
9.3. Late Onset
10. Pompe Disease Market, by Treatment Regimen
10.1. Introduction
10.2. Biweekly Infusion
10.3. Monthly Infusion
11. Pompe Disease Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Retail Pharmacy
11.4. Specialty Pharmacy
12. Americas Pompe Disease Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Pompe Disease Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Pompe Disease Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Sanofi S.A.
15.3.2. Amicus Therapeutics, Inc.
15.3.3. Shionogi Inc.
15.3.4. Maze Therapeutics
15.3.5. GeneCradle Pharmaceutical
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. POMPE DISEASE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL POMPE DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL POMPE DISEASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL POMPE DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL POMPE DISEASE MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL POMPE DISEASE MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2024 VS 2030 (%)
FIGURE 10. GLOBAL POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS POMPE DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS POMPE DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES POMPE DISEASE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES POMPE DISEASE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. POMPE DISEASE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. POMPE DISEASE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. POMPE DISEASE MARKET: RESEARCHAI
FIGURE 24. POMPE DISEASE MARKET: RESEARCHSTATISTICS
FIGURE 25. POMPE DISEASE MARKET: RESEARCHCONTACTS
FIGURE 26. POMPE DISEASE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. POMPE DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL POMPE DISEASE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL POMPE DISEASE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL POMPE DISEASE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL POMPE DISEASE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL POMPE DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL POMPE DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL POMPE DISEASE MARKET SIZE, BY ALGLUCOSIDASE ALFA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL POMPE DISEASE MARKET SIZE, BY ALGLUCOSIDASE ALFA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL POMPE DISEASE MARKET SIZE, BY AVALGLUCOSIDASE ALFA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL POMPE DISEASE MARKET SIZE, BY AVALGLUCOSIDASE ALFA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL POMPE DISEASE MARKET SIZE, BY INFANTILE ONSET, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL POMPE DISEASE MARKET SIZE, BY INFANTILE ONSET, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL POMPE DISEASE MARKET SIZE, BY LATE ONSET, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL POMPE DISEASE MARKET SIZE, BY LATE ONSET, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL POMPE DISEASE MARKET SIZE, BY BIWEEKLY INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL POMPE DISEASE MARKET SIZE, BY BIWEEKLY INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL POMPE DISEASE MARKET SIZE, BY MONTHLY INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL POMPE DISEASE MARKET SIZE, BY MONTHLY INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL POMPE DISEASE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL POMPE DISEASE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL POMPE DISEASE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL POMPE DISEASE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL POMPE DISEASE MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL POMPE DISEASE MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. AMERICAS POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 36. AMERICAS POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 37. AMERICAS POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 38. AMERICAS POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 39. AMERICAS POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 40. AMERICAS POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 41. AMERICAS POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. AMERICAS POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS POMPE DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS POMPE DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 45. UNITED STATES POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 46. UNITED STATES POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 47. UNITED STATES POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 48. UNITED STATES POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 49. UNITED STATES POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 50. UNITED STATES POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 51. UNITED STATES POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 52. UNITED STATES POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 53. UNITED STATES POMPE DISEASE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 54. UNITED STATES POMPE DISEASE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 55. CANADA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 56. CANADA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 57. CANADA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 58. CANADA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 59. CANADA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 60. CANADA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 61. CANADA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. CANADA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. MEXICO POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 64. MEXICO POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 65. MEXICO POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 66. MEXICO POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 67. MEXICO POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 68. MEXICO POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 69. MEXICO POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. MEXICO POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. BRAZIL POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 72. BRAZIL POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 73. BRAZIL POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 74. BRAZIL POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 75. BRAZIL POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 76. BRAZIL POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 77. BRAZIL POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. BRAZIL POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. ARGENTINA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 80. ARGENTINA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 81. ARGENTINA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 82. ARGENTINA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 83. ARGENTINA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 84. ARGENTINA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 85. ARGENTINA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. ARGENTINA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 98. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 100. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 102. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. GERMANY POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 106. GERMANY POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 107. GERMANY POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 108. GERMANY POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 109. GERMANY POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 110. GERMANY POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 111. GERMANY POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. GERMANY POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. FRANCE POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 114. FRANCE POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 115. FRANCE POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 116. FRANCE POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 117. FRANCE POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 118. FRANCE POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 119. FRANCE POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. FRANCE POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. RUSSIA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 122. RUSSIA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 123. RUSSIA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 124. RUSSIA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 125. RUSSIA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 126. RUSSIA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 127. RUSSIA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. RUSSIA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. ITALY POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 130. ITALY POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 131. ITALY POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 132. ITALY POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 133. ITALY POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 134. ITALY POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 135. ITALY POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. ITALY POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. SPAIN POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 138. SPAIN POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 139. SPAIN POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 140. SPAIN POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 141. SPAIN POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 142. SPAIN POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 143. SPAIN POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. SPAIN POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 154. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 156. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 158. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 162. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 164. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 166. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. DENMARK POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 170. DENMARK POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 171. DENMARK POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 172. DENMARK POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 173. DENMARK POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 174. DENMARK POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 175. DENMARK POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. DENMARK POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. NETHERLANDS POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 178. NETHERLANDS POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 179. NETHERLANDS POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 180. NETHERLANDS POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 181. NETHERLANDS POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 182. NETHERLANDS POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 183. NETHERLANDS POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. NETHERLANDS POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. QATAR POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 186. QATAR POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 187. QATAR POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 188. QATAR POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 189. QATAR POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 190. QATAR POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 191. QATAR POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. QATAR POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. FINLAND POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 194. FINLAND POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 195. FINLAND POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 196. FINLAND POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 197. FINLAND POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 198. FINLAND POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 199. FINLAND POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. FINLAND POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. SWEDEN POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 202. SWEDEN POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 203. SWEDEN POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 204. SWEDEN POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 205. SWEDEN POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 206. SWEDEN POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 207. SWEDEN POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. SWEDEN POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. NIGERIA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 210. NIGERIA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 211. NIGERIA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 212. NIGERIA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 213. NIGERIA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 214. NIGERIA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 215. NIGERIA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. NIGERIA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. EGYPT POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 218. EGYPT POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 219. EGYPT POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 220. EGYPT POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 221. EGYPT POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 222. EGYPT POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 223. EGYPT POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. EGYPT POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. TURKEY POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 226. TURKEY POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 227. TURKEY POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 228. TURKEY POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 229. TURKEY POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 230. TURKEY POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 231. TURKEY POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. TURKEY POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. ISRAEL POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 234. ISRAEL POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 235. ISRAEL POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 236. ISRAEL POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 237. ISRAEL POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 238. ISRAEL POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 239. ISRAEL POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. ISRAEL POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. NORWAY POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 242. NORWAY POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 243. NORWAY POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 244. NORWAY POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 245. NORWAY POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 246. NORWAY POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 247. NORWAY POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. NORWAY POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. POLAND POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 250. POLAND POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 251. POLAND POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 252. POLAND POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 253. POLAND POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 254. POLAND POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 255. POLAND POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. POLAND POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. SWITZERLAND POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 258. SWITZERLAND POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 259. SWITZERLAND POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 260. SWITZERLAND POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 261. SWITZERLAND POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 262. SWITZERLAND POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 263. SWITZERLAND POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. SWITZERLAND POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 266. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 268. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 270. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 274. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 275. CHINA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 276. CHINA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 277. CHINA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 278. CHINA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 279. CHINA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 280. CHINA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 281. CHINA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. CHINA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. INDIA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 284. INDIA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 285. INDIA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 286. INDIA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 287. INDIA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 288. INDIA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 289. INDIA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. INDIA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. JAPAN POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 292. JAPAN POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 293. JAPAN POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 294. JAPAN POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 295. JAPAN POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 296. JAPAN POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 297. JAPAN POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. JAPAN POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. AUSTRALIA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 300. AUSTRALIA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 301. AUSTRALIA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 302. AUSTRALIA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 303. AUSTRALIA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 304. AUSTRALIA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 305. AUSTRALIA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. AUSTRALIA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 308. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 309. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 310. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 311. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 312. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 313. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. INDONESIA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 316. INDONESIA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 317. INDONESIA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 318. INDONESIA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 319. INDONESIA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 320. INDONESIA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 321. INDONESIA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. INDONESIA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. THAILAND POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 324. THAILAND POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 325. THAILAND POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 326. THAILAND POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 327. THAILAND POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 328. THAILAND POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 329. THAILAND POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. THAILAND POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. PHILIPPINES POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 332. PHILIPPINES POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 333. PHILIPPINES POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 334. PHILIPPINES POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 335. PHILIPPINES POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 336. PHILIPPINES POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 337. PHILIPPINES POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 338. PHILIPPINES POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 339. MALAYSIA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 340. MALAYSIA POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 341. MALAYSIA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 342. MALAYSIA POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 343. MALAYSIA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 344. MALAYSIA POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 345. MALAYSIA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 346. MALAYSIA POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 347. SINGAPORE POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 348. SINGAPORE POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 349. SINGAPORE POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 350. SINGAPORE POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 351. SINGAPORE POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 352. SINGAPORE POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 353. SINGAPORE POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 354. SINGAPORE POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 355. VIETNAM POMPE DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 356. VIETNAM POMPE DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 357. VIETNAM POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 358. VIETNAM POMPE DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 359. VIETNAM POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2018-2024 (USD MILLION)
TABLE 360. VIETNAM POMPE DISEASE MARKET SIZE, BY TREATMENT REGIMEN, 2025-2030 (USD MILLION)
TABLE 361. VIETNAM POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 362. VIETNAM POMPE DISEASE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 363. TAIWAN POMPE DISEASE MARKET SIZE, BY PRODUCT,

Samples

Loading
LOADING...

Companies Mentioned

  • Sanofi S.A.
  • Amicus Therapeutics, Inc.
  • Shionogi Inc.
  • Maze Therapeutics
  • GeneCradle Pharmaceutical

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.68 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.21 Billion
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned5

Related Topics

Related Reports

Pompe Disease Treatment Market 2025-2033 - Product Image

Pompe Disease Treatment Market 2025-2033

  • Report
  • 138 Pages
  • Global
From
Pompe Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Pompe Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Pompe Disease Market Report 2025 - Product Image

Pompe Disease Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Pompe Disease - Pipeline Insight, 2025 - Product Image

Pompe Disease - Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Lumizyme Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Lumizyme Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From

About the Pompe Disease Drug Market

Pompe Disease is a rare, inherited disorder caused by a deficiency of the enzyme alpha-glucosidase. This deficiency leads to the accumulation of glycogen in the lysosomes of cells, resulting in progressive muscle weakness and respiratory failure. Endocrine and Metabolic Disorders Drugs are used to treat Pompe Disease. These drugs are designed to replace the missing enzyme, allowing the body to break down the accumulated glycogen and restore normal muscle function. The Pompe Disease Drug market is a rapidly growing segment of the Endocrine and Metabolic Disorders Drugs market. The increasing prevalence of Pompe Disease and the availability of effective treatments have driven the growth of this market. Companies in this market are focused on developing treatments that are safe and effective, as well as improving existing treatments. Some companies in the Pompe Disease Drug market include Sanofi, Pfizer, Amicus Therapeutics, and Ultragenyx Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.